Evidence map›Paper›PMID 27733447›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2017

Pharmacologic activation of estrogen receptor β increases mitochondrial function, energy expenditure, and brown adipose tissue.

Suriyan Ponnusamy, Quynh T Tran, Innocence Harvey, Heather S Smallwood, Thirumagal Thiyagarajan, Souvik Banerjee, Daniel L Johnson, James T Dalton, Ryan D Sullivan, Duane D Miller and 2 more

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. A systematic review of exposure to endocrine disruptors and energy expenditure in mice.Environmental health : a global access science source · 2025
    Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The evolutionary impact and influence of oestrogens on adipose tissue structure and function.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  12. Article
  13. Selective effects of estradiol on human corneal endothelial cells.bioRxiv : the preprint server for biology · 2023
    Article
  14. Review
  15. Review
  16. Heart Failure in Menopause: Treatment and New Approaches.International journal of molecular sciences · 2022
    Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Suriyan PonnusamyDepartment of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Quynh T TranDepartment of Preventive Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Innocence HarveyDepartment of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Heather S SmallwoodDepartment of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Thirumagal ThiyagarajanDepartment of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Souvik BanerjeeDepartment of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Daniel L JohnsonMolecular Informatics Core, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
James T DaltonPreclinical Research and Development, GTx, Incorporated, Memphis, Tennessee, USA.
Ryan D SullivanDepartment of Comparative Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA; and.
Duane D MillerDepartment of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Dave BridgesDepartment of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Ramesh NarayananDepartment of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA; rnaraya4@uthsc.edu.
University of Tennessee Health Science Center · USGTx (United States) · USMemphis Health Center · US

Funding

Regulation of Lipid Storage by mTORC1R01DK107535 · NIDDK · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI BRIDGES, DAVE · 2016 to 2020
$1.7M
NIDDK NIH HHS R01 DK107535
6 · The paper itself

Abstract

Most satiety-inducing obesity therapeutics, despite modest efficacy, have safety concerns that underscore the need for effective peripherally acting drugs. An attractive therapeutic approach for obesity is to optimize/maximize energy expenditure by increasing energy-utilizing thermogenic brown adipose tissue. We used in vivo and in vitro models to determine the role of estrogen receptor β (ER-β) and its ligands on adipose biology. RNA sequencing and metabolomics were used to determine the mechanism of action of ER-β and its ligands. Estrogen receptor β (ER-β) and its selective ligand reprogrammed preadipocytes and precursor stem cells into brown adipose tissue and increased mitochondrial respiration. An ER-β-selective ligand increased markers of tricarboxylic acid-dependent and -independent energy biogenesis and oxygen consumption in mice without a concomitant increase in physical activity or food consumption, all culminating in significantly reduced weight gain and adiposity. The antiobesity effects of ER-β ligand were not observed in ER-β-knockout mice. Serum metabolite profiles of adult lean and juvenile mice were comparable, while that of adult obese mice was distinct, indicating a possible impact of obesity on age-dependent metabolism. This phenotype was partially reversed by ER-β-selective ligand. These data highlight a new role for ER-β in adipose biology and its potential to be a safer alternative peripheral therapeutic target for obesity.-Ponnusamy, S., Tran, Q. T., Harvey, I., Smallwood, H. S., Thiyagarajan, T., Banerjee, S., Johnson, D. L., Dalton, J. T., Sullivan, R. D., Miller, D. D., Bridges, D., Narayanan, R. Pharmacologic activation of estrogen receptor β increases mitochondrial function, energy expenditure, and brown adipose tissue.

Indexed as

Adipose Tissue, BrownAdipose Tissue, WhiteAnimalsBiomarkersDiet, High-FatEnergy MetabolismEstrogen Receptor betaGene Expression RegulationInsulin ResistanceIsoquinolinesMaleMiceMice, KnockoutMitochondriaObesitybeta-LGND2BiomarkersEstrogen Receptor betaIsoquinolinesexercise mimeticmetabolic diseasesmitochondriaobesityoxygen consumption

Identifiers

PMID27733447
PMCPMC5161516
OpenAlexW2530492717

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.